Toward standardization and translation of stem cell therapy in liver failure
Date unavailable
← Back to Journals
Annals of Hepatology
- Publisher:
- Elsevier
- ISSN:
- 1665-2681
- Category:
- GASTROENTEROLOGY & HEPATOLOGY
- Impact factor:
- 3.7
Feed status
31 parsed articles
Last update: Not fetched
Latest articles
Name MASLD/MASH — and act on it
Date unavailable
Early-life exposure to tobacco smoke and chronic liver disease incidence in adulthood
Date unavailable
Comment on “Comparisons of global incidence and risk factor profiles of hepatocellular carcinoma and intrahepatic cholangiocarcinoma”
Date unavailable
Left-sided portal hypertension: Local venous congestion without ascites
Date unavailable
Metabolic dysfunction–associated steatotic liver disease: No alcohol
Date unavailable
Comment on “A three-gene resistome signature as a prognostic tool in hepatocellular carcinoma”.
Date unavailable
Pancreatic involvement and its prognostic impact in acute-on-chronic liver failure
Date unavailable
Similar hepatic outcome by SGLT2i vs. DPP4i for at-risk cohort with CHB & T2DM: A nationwide target trial emulation study
Date unavailable
Reply to: Comment on “pancreatic involvement and its prognostic impact in acute-on chronic liver failure”
Date unavailable
A multinational survey of physician knowledge about management of chronic hepatitis C
Date unavailable
Antibiotic consumption, genetic risk and incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study
Date unavailable
Clinical and molecular implications of antipsychotics in MASLD
Date unavailable
The AMAGE guidelines: metabolic dysfunction-associated fatty liver disease through a regional lens
Date unavailable
Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab
Date unavailable
Noninvasive elastography-based assessment of liver fibrosis in primary biliary cholangitis
Date unavailable
Reevaluating the clinical course of AMA-positive patients with normal liver enzymes: A large retrospective cohort study
Date unavailable
Learning is not enough: enhancing the reach and rigor of hepatitis eLearning
Date unavailable
Is FIB-4 the right tool for screening for liver fibrosis?
Date unavailable
Aspartate aminotransferase‑to‑platelet ratio index (APRI) reliably excludes advanced fibrosis and cirrhosis in treated autoimmune hepatitis
Date unavailable
Genetic risk factors for MASLD/MASH and cardiovascular disease in elderly individuals
Date unavailable
Non-hepatic cancers in alcohol-related liver disease with insights for clinical management
Date unavailable
Prognosis of hepatocellular carcinoma in the French overseas territories and comparison with a tertiary center in mainland France
Date unavailable
Regression of fibrosis and portal hypertension in chronic liver disease: Endothelial perspectives and clinical implications
Date unavailable
Pruritus in primary biliary cholangitis: insights from the German PBC registry across secondary and tertiary care
Date unavailable
Overcoming barriers to HCV screening in Latin America: from evidence to action
Date unavailable
Serum bilirubin concentrations and their association with clinical and radiological outcomes in multiple sclerosis: A large cohort study
Date unavailable
A three-gene resistome signature as a prognostic tool in hepatocellular carcinoma
Date unavailable
<em>Re</em>-evaluating serum IL-6 as a prognostic biomarker in HCC immunotherapy with atezolizumab plus bevacizumab: the critical role of baseline liver function and disease etiology
Date unavailable
Comparisons of global incidence and risk factor profiles of hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Date unavailable